Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05384132 · ClinicalTrials.gov registry record · NA

Novel Dental Gel as an Adjunct to Scaling and Root Planing

A NA study of Periodontal Diseases and Gingival Diseases, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
76
Enrollment target
1
Study location

NCT05384132 is a NA study of Periodontal Diseases and Gingival Diseases that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 76 participants, below the 157-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05384132, a NA study of Periodontal Diseases and Gingival Diseases, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
76 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the use of Livionex Dental Gel (LDG) as a home care product in reducing probing pocket depth (PD) beyond the effect achieved by the current standard of care with SRP in periodontitis patients.

Interventions

  • OTHER SRP + Livfresh Dental Gel
  • OTHER SRP + standard flouride dentifrice

Study Locations (1)

Alabama

  • Unversity of Alabama at Birmingham, School of Dentistry - Birmingham

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2022-10-14
Est. Completion 2028-10-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05384132

The ClinicalTrials.gov registry entry for NCT05384132 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 157-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (52% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Periodontal Diseases appearing as the primary indexed condition, and to 2 interventions - of which SRP + Livfresh Dental Gel is the first listed.

NCT05384132 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05384132 about?

NCT05384132 is a clinical study titled "Novel Dental Gel as an Adjunct to Scaling and Root Planing". This study will evaluate the use of Livionex Dental Gel (LDG) as a home care product in reducing probing pocket depth (PD) beyond the effect achieved by the current standard of care with SRP in periodontitis patients.

What is the current status of trial NCT05384132?

This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2022-10-14. Estimated completion is 2028-10-30.

What conditions does trial NCT05384132 study?

This clinical trial studies the following conditions: Periodontal Diseases, Gingival Diseases, Plaque, Dental, Gingival Pocket, Gum Bleed.

What interventions are being tested in trial NCT05384132?

The interventions under investigation include: SRP + Livfresh Dental Gel (OTHER), SRP + standard flouride dentifrice (OTHER).

Who is sponsoring clinical trial NCT05384132?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05384132 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Periodontal Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.